Susanne J. Goldie, M.Ph.

Concepts (532)

Back to Profile

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name	Number of Publications	Most Recent Publication	Publications by All Authors	Concept Score	Why?
Uterine Cervical Neoplasms	55	2012	2039	4.870	Why?
Papillomavirus Vaccines	27	2012	497	4.410	Why?
Papillomavirus Infections	37	2011	1639	3.610	Why?
Cost-Benefit Analysis	103	2017	5536	2.490	Why?
Human papillomavirus 16	15	2011	268	2.400	Why?
Human papillomavirus 18	14	2011	125	2.330	Why?
Mass Screening	43	2015	5454	2.300	Why?
Maternal Mortality	5	2023	310	2.200	Why?
Uterine Cervical Dysplasia	12	2010	391	1.610	Why?
Vaccination	16	2017	3435	1.480	Why?
Papillomaviridae	15	2006	1139	1.480	Why?
Quality-Adjusted Life Years	39	2017	1740	1.370	Why?
Markov Chains	21	2010	974	1.290	Why?
Tumor Virus Infections	7	2004	438	1.070	Why?
Alphapapillomavirus	5	2011	219	1.070	Why?
AIDS-Related Opportunistic Infections	15	2007	663	1.020	Why?
Health Care Costs	21	2012	3240	0.980	Why?
Health Policy	13	2024	2697	0.970	Why?
Helicobacter Infections	5	2015	390	0.960	Why?
Stomach Neoplasms	6	2015	1480	0.940	Why?
Helicobacter pylori	5	2015	380	0.920	Why?
Developing Countries	11	2017	2912	0.920	Why?
Vaginal Smears	11	2011	505	0.880	Why?
Models, Theoretical	22	2013	3563	0.880	Why?
Rotavirus Vaccines	4	2011	62	0.840	Why?
Rotavirus Infections	4	2011	85	0.830	Why?
Immunization Programs	8	2017	267	0.810	Why?
DNA, Viral	14	2011	2201	0.760	Why?
Models, Economic	10	2010	719	0.690	Why?
Models, Econometric	10	2010	215	0.610	Why?
Decision Support Techniques	10	2016	2007	0.590	Why?
Anus Neoplasms	5	2008	336	0.540	Why?
Computer Simulation	20	2023	6258	0.540	Why?
Cost of Illness	8	2017	1949	0.530	Why?
Colposcopy	8	2008	151	0.520	Why?
Early Detection of Cancer	6	2012	3235	0.510	Why?
Pepsinogen A	1	2015	14	0.500	Why?
HIV Infections	32	2011	17532	0.470	Why?
Sexually Transmitted Diseases, Viral	2	2004	39	0.460	Why?
Chlamydia trachomatis	2	2006	239	0.440	Why?
Abortion, Induced	2	2010	471	0.440	Why?
Life Expectancy	19	2011	1248	0.430	Why?
Gastroscopy	1	2015	213	0.430	Why?
Delivery of Health Care	7	2023	5367	0.420	Why?
Female	112	2023	396532	0.410	Why?
Hepatitis C, Chronic	3	2007	1033	0.390	Why?
Chlamydia Infections	2	2006	365	0.390	Why?
Herpes Genitalis	2	2003	148	0.380	Why?
Adenocarcinoma	4	2015	6359	0.380	Why?
Humans	167	2024	766812	0.370	Why?
Adult	78	2015	223305	0.370	Why?
Precancerous Conditions	3	2010	980	0.350	Why?
Anti-HIV Agents	14	2011	4561	0.330	Why?
Office Visits	2	2006	593	0.330	Why?
Guideline Adherence	2	2011	2233	0.330	Why?
Empirical Research	1	2010	119	0.330	Why?
Hepatitis C	3	2004	1595	0.330	Why?
CD4 Lymphocyte Count	19	2010	2586	0.320	Why?
Antiretroviral Therapy, Highly Active	10	2010	1900	0.320	Why?
Maternal Health Services	3	2012	472	0.320	Why?
Program Evaluation	4	2012	2504	0.310	Why?
Syphilis, Congenital	1	2008	26	0.310	Why?
Anti-Infective Agents	3	2006	987	0.310	Why?
Cholera Vaccines	1	2011	264	0.310	Why?
Viral Vaccines	2	2004	596	0.300	Why?
Diagnostic Tests, Routine	3	2004	788	0.300	Why?
Disease Outbreaks	2	2011	1761	0.300	Why?
Diagnostic Techniques and Procedures	2	2008	216	0.300	Why?
Models, Statistical	7	2016	5092	0.290	Why?
United States	45	2015	72945	0.290	Why?
Sensitivity and Specificity	22	2010	14653	0.280	Why?
Pelvic Inflammatory Disease	2	2006	95	0.270	Why?
Pneumococcal Vaccines	1	2010	414	0.270	Why?
Hepatitis B Vaccines	1	2007	178	0.270	Why?
Antiviral Agents	6	2007	3070	0.260	Why?
Uncertainty	3	2023	765	0.260	Why?
Forecasting	4	2023	2936	0.260	Why?
Health Services Administration	1	2006	63	0.260	Why?
Pneumococcal Infections	1	2010	529	0.250	Why?
Models, Biological	11	2010	9464	0.250	Why?
Monte Carlo Method	6	2017	1251	0.250	Why?
Ribavirin	2	2007	396	0.250	Why?
Interferon-alpha	3	2007	910	0.250	Why?
Developed Countries	1	2008	453	0.250	Why?
Adolescent	28	2012	88902	0.250	Why?
Cholera	1	2011	754	0.240	Why?
Primary Prevention	3	2016	1188	0.240	Why?
Epidemiologic Research Design	1	2008	368	0.240	Why?
Calibration	4	2009	814	0.230	Why?
Herpesvirus 2, Human	2	2003	191	0.230	Why?
Delivery of Health Care, Integrated	1	2012	949	0.230	Why?
Middle Aged	46	2015	223267	0.220	Why?
Health Resources	2	2006	950	0.220	Why?
Mortality	3	2023	2908	0.210	Why?
Genital Neoplasms, Female	1	2008	534	0.210	Why?
Drug Costs	8	2010	1194	0.210	Why?
Family Planning Services	3	2012	277	0.210	Why?
Pneumonia, Pneumocystis	2	2002	242	0.210	Why?
Anti-Retroviral Agents	3	2008	1787	0.210	Why?
Smoking	4	2016	9077	0.200	Why?
DNA Probes, HPV	3	2008	21	0.200	Why?
Pentamidine	1	2002	44	0.200	Why?
Practice Guidelines as Topic	4	2011	7430	0.200	Why?
Dapsone	1	2002	55	0.200	Why?
Naphthoquinones	1	2002	60	0.200	Why?
Therapeutics	1	2002	113	0.200	Why?
Hepatitis B	1	2007	710	0.200	Why?
Oncogene Proteins, Viral	1	2003	342	0.190	Why?
Antiprotozoal Agents	1	2002	93	0.190	Why?
Carcinoma, Squamous Cell	6	2006	4050	0.190	Why?
HIV	4	2010	1588	0.190	Why?
Prenatal Diagnosis	1	2008	1271	0.180	Why?
Disease Progression	14	2010	13642	0.180	Why?
Bisexuality	2	2000	295	0.180	Why?
HIV Seropositivity	2	2006	962	0.180	Why?
Time Management	1	2001	53	0.180	Why?
Mass Media	1	2004	303	0.180	Why?
Gonorrhea	1	2005	355	0.180	Why?
Health Education	3	2004	1060	0.180	Why?
Pregnancy Outcome	3	2011	2971	0.180	Why?
Incidence	12	2015	21527	0.170	Why?
Women's Health Services	1	2001	87	0.170	Why?
Pregnancy	14	2012	30236	0.170	Why?
Endoscopy	1	2010	1854	0.170	Why?
China	4	2010	2386	0.170	Why?
Dilatation and Curettage	2	2010	53	0.170	Why?
Asia	3	2011	629	0.170	Why?
Vacuum Curettage	2	2010	44	0.170	Why?
Pregnancy Complications, Infectious	4	2011	2183	0.170	Why?
Health Status Disparities	1	2011	1880	0.170	Why?
Point-of-Care Systems	1	2008	1217	0.170	Why?
Risk Factors	23	2016	74889	0.160	Why?
Gambia	2	2010	104	0.160	Why?
Abortifacient Agents, Nonsteroidal	2	2010	65	0.160	Why?
HIV Seronegativity	1	2000	209	0.160	Why?
Policy	1	2023	512	0.160	Why?
Choice Behavior	2	2002	846	0.160	Why?
Molecular Diagnostic Techniques	1	2004	614	0.160	Why?
Brazil	3	2007	1250	0.160	Why?
Child	19	2012	80670	0.160	Why?
Misoprostol	2	2010	94	0.160	Why?
Sexually Transmitted Diseases	2	2005	668	0.160	Why?
Communicable Disease Control	2	2017	857	0.160	Why?
Drug Resistance, Viral	4	2007	868	0.150	Why?
Nigeria	2	2012	781	0.150	Why?
Pharyngeal Neoplasms	2	2008	113	0.150	Why?
RNA, Viral	8	2006	2867	0.150	Why?
Risk Reduction Behavior	2	2016	1120	0.150	Why?
Cesarean Section	2	2004	1418	0.150	Why?
Mexico	3	2010	769	0.150	Why?
Polyethylene Glycols	1	2003	1189	0.140	Why?
Direct Service Costs	4	2006	61	0.140	Why?
Patient Compliance	2	2006	2694	0.140	Why?
Neoplasms	5	2011	22350	0.140	Why?
Stochastic Processes	2	2008	359	0.140	Why?
Mass Vaccination	2	2008	111	0.140	Why?
Public Health	5	2015	2680	0.140	Why?
Decision Trees	3	2009	508	0.140	Why?
Genetic Diseases, Inborn	1	2001	606	0.140	Why?
Physical Examination	1	2002	1265	0.130	Why?
Cytodiagnosis	2	2004	450	0.130	Why?
South Africa	4	2009	1873	0.130	Why?
Streptococcal Infections	1	2001	618	0.130	Why?
Male	44	2015	364154	0.130	Why?
Age Factors	9	2009	18397	0.130	Why?
West Nile Fever	2	2006	77	0.130	Why?
Healthcare Disparities	1	2011	3411	0.130	Why?
Health Services Research	3	2011	1811	0.120	Why?
Pregnancy Trimester, First	2	2010	917	0.120	Why?
Overweight	1	2006	2447	0.120	Why?
Weight Loss	1	2006	2712	0.120	Why?
Yoga	2	2016	277	0.120	Why?
Patient Education as Topic	1	2004	2334	0.110	Why?
Time Factors	11	2013	40149	0.110	Why?
Caribbean Region	3	2008	193	0.110	Why?
Vietnam	3	2010	413	0.110	Why?
Cholesterol	1	2002	2904	0.110	Why?
Age Distribution	4	2009	2869	0.110	Why?
Risk	4	2009	9602	0.110	Why?
Staphylococcal Infections	3	2001	1396	0.110	Why?
Pregnancy Complications	1	2007	2971	0.110	Why?
Mouth Neoplasms	2	2008	597	0.100	Why?
Latin America	3	2008	416	0.100	Why?
Cote d'Ivoire	3	2007	65	0.100	Why?
Preventive Medicine	2	2007	246	0.100	Why?
India	2	2010	2335	0.100	Why?
Family Planning Policy	1	2012	7	0.100	Why?
Afghanistan	1	2012	78	0.100	Why?
Pacific Islands	2	2008	52	0.100	Why?
Quality of Life	8	2008	13476	0.100	Why?
Homosexuality, Male	1	2000	1342	0.100	Why?
Health Expenditures	4	2018	2389	0.100	Why?
Africa, Eastern	1	2011	76	0.100	Why?
Young Adult	9	2013	59939	0.100	Why?
Infant	7	2011	36459	0.090	Why?
Zimbabwe	1	2011	135	0.090	Why?
Immunity, Herd	1	2011	48	0.090	Why?
Cohort Studies	13	2010	41706	0.090	Why?
Aged	21	2014	171344	0.090	Why?
Costs and Cost Analysis	3	2008	1667	0.090	Why?
Acquired Immunodeficiency Syndrome	4	2010	2204	0.090	Why?
Health Services Accessibility	5	2012	5513	0.090	Why?
France	4	2005	496	0.090	Why?
Air Bags	3	2001	12	0.090	Why?
Financial Support	1	2011	116	0.090	Why?
International Agencies	1	2011	244	0.090	Why?
Recombinant Proteins	3	2007	6507	0.090	Why?
Ganciclovir	3	2001	256	0.090	Why?
Teratogens	1	2011	119	0.090	Why?
Arthroplasty, Replacement, Hip	1	2001	1417	0.090	Why?
Insurance Claim Reporting	1	2011	166	0.090	Why?
Population Surveillance	3	2010	2594	0.090	Why?
Risk Assessment	7	2016	24299	0.080	Why?
Patient Satisfaction	1	2002	3485	0.080	Why?
Marketing of Health Services	1	2011	151	0.080	Why?
Directly Observed Therapy	1	2010	139	0.080	Why?
Peru	1	2012	888	0.080	Why?
Decision Making, Organizational	2	2008	136	0.080	Why?
Prevalence	5	2008	15835	0.080	Why?
Rotavirus	1	2010	110	0.080	Why?
Emergency Service, Hospital	2	2007	7870	0.080	Why?
Benzoxazines	1	2011	320	0.080	Why?
Intensive Care, Neonatal	1	2010	201	0.080	Why?
Ghana	1	2010	333	0.080	Why?
Health Services Misuse	1	2011	245	0.080	Why?
Africa	1	2011	725	0.080	Why?
Communicable Diseases	1	2017	872	0.080	Why?
Vaccines, Conjugate	1	2010	334	0.080	Why?
Reagent Strips	1	2008	40	0.080	Why?
Human papillomavirus 11	1	2008	14	0.080	Why?
Human papillomavirus 6	1	2008	16	0.080	Why?
Condylomata Acuminata	1	2008	79	0.080	Why?
Respiratory Tract Neoplasms	1	2008	56	0.080	Why?
Genetic Testing	1	2001	3591	0.080	Why?
Drug Therapy, Combination	6	2006	6306	0.080	Why?
Infectious Disease Transmission, Vertical	3	2010	1353	0.080	Why?
Warts	1	2008	66	0.070	Why?
Abnormalities, Drug-Induced	1	2011	337	0.070	Why?
Cytomegalovirus Infections	3	2001	838	0.070	Why?
Health Planning Guidelines	1	2008	151	0.070	Why?
Endometrial Neoplasms	2	2007	1381	0.070	Why?
Vaccines, Attenuated	1	2009	314	0.070	Why?
Vaginal Neoplasms	1	2008	105	0.070	Why?
Aged, 80 and over	7	2013	59548	0.070	Why?
Pregnancy Trimester, Third	1	2010	587	0.070	Why?
Papilloma	1	2008	143	0.070	Why?
Colombia	1	2008	287	0.070	Why?
Virology	2	2005	76	0.070	Why?
Patient Selection	3	2016	4252	0.070	Why?
Treatment Outcome	12	2014	65286	0.070	Why?
Microbial Sensitivity Tests	2	2005	1972	0.070	Why?
Health Status	3	2014	4087	0.070	Why?
Health Status Indicators	2	2002	968	0.070	Why?
Penile Neoplasms	1	2008	158	0.070	Why?
Public Policy	1	2010	551	0.070	Why?
False Positive Reactions	1	2008	958	0.060	Why?
West Nile virus	1	2006	77	0.060	Why?
Decision Making	5	2008	3951	0.060	Why?
Life Style	2	2016	3926	0.060	Why?
Budgets	2	2005	232	0.060	Why?
Nutrition Surveys	1	2013	1737	0.060	Why?
Health Care Rationing	3	2007	435	0.060	Why?
Africa South of the Sahara	1	2008	751	0.060	Why?
Vulvar Neoplasms	1	2008	266	0.060	Why?
Penicillins	1	2008	404	0.060	Why?
Carcinoma	2	2009	2325	0.060	Why?
Smoking Cessation	2	2016	2085	0.060	Why?
Atrioventricular Node	1	2006	180	0.060	Why?
Sentinel Surveillance	1	2007	292	0.060	Why?
Breast Neoplasms	2	2011	21162	0.060	Why?
Adolescent Health Services	1	2007	217	0.060	Why?
National Health Programs	1	2008	443	0.060	Why?
HIV Fusion Inhibitors	1	2005	82	0.060	Why?
Immunotherapy, Active	1	2004	58	0.060	Why?
Gynecologic Surgical Procedures	1	2007	287	0.060	Why?
Urban Health	1	2007	532	0.060	Why?
Child, Preschool	5	2011	42577	0.060	Why?
Actuarial Analysis	1	2004	370	0.060	Why?
Triage	2	2008	995	0.060	Why?
Hong Kong	1	2004	169	0.060	Why?
Rape	1	2005	131	0.060	Why?
Heart Block	1	2006	391	0.060	Why?
Referral and Consultation	2	2008	3618	0.060	Why?
Evidence-Based Practice	1	2008	499	0.060	Why?
Cancer Vaccines	1	2011	1042	0.060	Why?
Obesity	1	2006	13090	0.060	Why?
Epidemiologic Methods	1	2008	1326	0.050	Why?
Germany	1	2006	882	0.050	Why?
HIV-1	5	2007	6948	0.050	Why?
Chemoprevention	2	2002	327	0.050	Why?
HIV Envelope Protein gp41	1	2005	306	0.050	Why?
Preventive Health Services	2	2015	570	0.050	Why?
Italy	1	2005	856	0.050	Why?
Infant, Newborn	5	2010	26387	0.050	Why?
Acetic Acid	1	2002	58	0.050	Why?
Income	2	2002	1876	0.050	Why?
Diet, Reducing	1	2006	487	0.050	Why?
Nucleic Acid Amplification Techniques	1	2005	335	0.050	Why?
Anti-Obesity Agents	1	2006	241	0.050	Why?
Neisseria gonorrhoeae	1	2005	249	0.050	Why?
Social Class	1	2011	2007	0.050	Why?
Oropharyngeal Neoplasms	1	2008	492	0.050	Why?
Atovaquone	1	2002	56	0.050	Why?
Body Constitution	1	2002	273	0.050	Why?
Disease-Free Survival	2	2003	6853	0.050	Why?
Resource Allocation	1	2004	354	0.050	Why?
Massachusetts	3	2011	8890	0.050	Why?
Primary Health Care	1	2018	4735	0.050	Why?
Genotype	3	2007	13036	0.050	Why?
Pregnancy, Ectopic	1	2003	146	0.050	Why?
Infant Equipment	1	2001	23	0.050	Why?
Medical Assistance	1	2002	108	0.050	Why?
Social Values	1	2002	224	0.050	Why?
Cause of Death	3	2010	3717	0.050	Why?
Cost Allocation	1	2001	48	0.050	Why?
Fibrosis	1	2008	2078	0.050	Why?
Seroepidemiologic Studies	1	2002	404	0.050	Why?
Rural Health Services	1	2005	393	0.050	Why?
Television	1	2004	409	0.050	Why?
Condoms	1	2003	336	0.040	Why?
Value of Life	1	2001	98	0.040	Why?
Longitudinal Studies	2	2007	14762	0.040	Why?
Automobiles	1	2001	103	0.040	Why?
Heterosexuality	1	2003	308	0.040	Why?
Vancomycin	2	2001	504	0.040	Why?
Pelvic Pain	1	2003	300	0.040	Why?
Netherlands	1	2005	2277	0.040	Why?
DNA, Bacterial	1	2005	1477	0.040	Why?
State Health Plans	1	2002	220	0.040	Why?
Delivery, Obstetric	1	2007	949	0.040	Why?
Women, Working	1	2001	86	0.040	Why?
Cardiovascular Diseases	3	2016	15652	0.040	Why?
Pacemaker, Artificial	1	2006	828	0.040	Why?
Insurance, Pharmaceutical Services	1	2002	347	0.040	Why?
Cardiovascular Agents	1	2006	849	0.040	Why?
Survivors	1	2010	2379	0.040	Why?
Epidemiologic Studies	1	2002	677	0.040	Why?
Policy Making	1	2002	546	0.040	Why?
Survival Analysis	3	2007	10101	0.040	Why?
Healthy People Programs	1	2018	54	0.040	Why?
Homosexuality	1	1999	268	0.040	Why?
Salaries and Fringe Benefits	1	2001	263	0.040	Why?
Viral Load	2	2010	3385	0.040	Why?
Educational Status	2	2003	2510	0.040	Why?
Debridement	1	2001	494	0.040	Why?
AIDS Vaccines	1	2004	898	0.040	Why?
International Cooperation	2	2015	1434	0.040	Why?
Logistic Models	2	2011	13276	0.040	Why?
Mammography	1	2008	2429	0.040	Why?
Drug Administration Schedule	2	2002	4853	0.040	Why?
Randomized Controlled Trials as Topic	4	2014	10384	0.040	Why?
Public Health Practice	1	2000	219	0.040	Why?
Posture	1	2001	955	0.030	Why?
Infertility, Female	1	2003	763	0.030	Why?
Peritoneal Dialysis, Continuous Ambulatory	1	1996	29	0.030	Why?
Appointments and Schedules	1	2001	442	0.030	Why?
Medical Oncology	1	2009	2340	0.030	Why?
Safety	1	2001	1157	0.030	Why?
Cytomegalovirus	2	2001	754	0.030	Why?
Antibiotic Prophylaxis	1	2001	641	0.030	Why?
Defibrillators, Implantable	1	2006	1499	0.030	Why?
Biopsy	1	2008	6779	0.030	Why?
Medically Uninsured	1	2001	838	0.030	Why?
Neoplasm Staging	3	2007	11218	0.030	Why?
Carcinoma, Hepatocellular	1	2008	2329	0.030	Why?
Accidents, Traffic	1	2001	818	0.030	Why?
Diagnostic Errors	1	2003	1276	0.030	Why?
Enzyme-Linked Immunosorbent Assay	1	2003	3803	0.030	Why?
Urban Population	1	2003	2040	0.030	Why?
Sex Factors	1	2009	10619	0.030	Why?
Child Behavior	1	2001	864	0.030	Why?
Air Pollution, Indoor	1	2003	931	0.030	Why?
Morbidity	1	2001	1754	0.030	Why?
Information Dissemination	1	2004	1142	0.030	Why?
Blotting, Western	1	2003	5022	0.030	Why?
Frail Elderly	1	2001	781	0.030	Why?
Health Care Surveys	1	2002	2425	0.030	Why?
Polymerase Chain Reaction	2	2001	6066	0.030	Why?
Attitude to Health	1	2004	2021	0.030	Why?
Community Health Planning	1	2015	164	0.030	Why?
Liver Diseases	1	2003	1303	0.030	Why?
Software	1	2008	4464	0.030	Why?
Reproducibility of Results	3	2008	20146	0.030	Why?
Peritonitis	1	1996	368	0.030	Why?
Rural Population	1	2005	2321	0.030	Why?
Information Systems	1	1976	400	0.030	Why?
Financing, Organized	1	2015	202	0.030	Why?
Medicaid	2	2005	2836	0.030	Why?
Investments	1	2015	148	0.030	Why?
Cell Transformation, Neoplastic	1	2003	2841	0.030	Why?
Gynecology	1	1999	534	0.030	Why?
Chi-Square Distribution	2	2014	3431	0.030	Why?
Body Composition	1	2002	2441	0.030	Why?
Genomics	1	2009	5922	0.030	Why?
Liver Cirrhosis	1	2003	1960	0.030	Why?
Databases, Factual	1	2008	8065	0.030	Why?
Peptide Fragments	1	2005	5143	0.030	Why?
Obstetrics	1	1999	679	0.030	Why?
Coronary Artery Bypass	1	2001	2189	0.020	Why?
Surgical Wound Infection	1	2001	1547	0.020	Why?
Financing, Government	1	2015	473	0.020	Why?
Colorectal Neoplasms	1	2011	6965	0.020	Why?
Comparative Effectiveness Research	1	2016	713	0.020	Why?
Adipose Tissue	1	2002	3317	0.020	Why?
Goals	1	2015	717	0.020	Why?
Alkynes	1	2011	326	0.020	Why?
Prognosis	2	2016	29959	0.020	Why?
Seat Belts	2	2001	60	0.020	Why?
Health Knowledge, Attitudes, Practice	1	2004	4056	0.020	Why?
Population	1	2009	140	0.020	Why?
Cyclopropanes	1	2011	436	0.020	Why?
Diet, Mediterranean	1	2016	746	0.020	Why?
Spain	1	2010	483	0.020	Why?
Vaccines	1	2017	842	0.020	Why?
Cytological Techniques	1	2010	217	0.020	Why?
Survival Rate	1	2002	12826	0.020	Why?
Follow-Up Studies	2	2007	39312	0.020	Why?
Recurrence	1	2001	8507	0.020	Why?
Predictive Value of Tests	2	2001	15425	0.020	Why?
Patient Acceptance of Health Care	1	2002	3230	0.020	Why?
Cross Infection	1	1996	1427	0.020	Why?
American Cancer Society	1	2007	69	0.020	Why?
Toxoplasmosis, Cerebral	1	2006	19	0.020	Why?
Liver Neoplasms	1	2002	4356	0.020	Why?
Drug Resistance, Microbial	2	2001	832	0.020	Why?
Mycobacterium Infections	1	2006	122	0.020	Why?
Isoproterenol	1	2006	398	0.020	Why?
Wounds and Injuries	1	1998	2513	0.020	Why?
Anti-Bacterial Agents	2	2001	7475	0.020	Why?
Severity of Illness Index	1	2003	15912	0.020	Why?
HIV Protease Inhibitors	1	2007	430	0.010	Why?
Georgia	1	2005	186	0.010	Why?
Probability	1	2010	2476	0.010	Why?
Regression Analysis	2	2006	6329	0.010	Why?
Adrenergic beta-Agonists	1	2006	345	0.010	Why?
Social Justice	1	2009	484	0.010	Why?
Asthma	1	2003	6266	0.010	Why?
Reverse Transcriptase Inhibitors	1	2007	618	0.010	Why?
Psychiatry	1	1976	1715	0.010	Why?
Blood Donors	1	2006	344	0.010	Why?
Tachycardia	1	2006	598	0.010	Why?
Health Promotion	1	2015	2209	0.010	Why?
Hospitalization	2	2001	10816	0.010	Why?
Haiti	1	2005	553	0.010	Why?
Mycoses	1	2006	389	0.010	Why?
Electrophysiologic Techniques, Cardiac	1	2006	511	0.010	Why?
Occupations	1	2005	516	0.010	Why?
World Health Organization	1	2008	1327	0.010	Why?
Radiotherapy, Adjuvant	1	2007	1788	0.010	Why?
Multivariate Analysis	2	2006	12064	0.010	Why?
Algorithms	2	2002	14073	0.010	Why?
Pediatric Assistants	1	2001	8	0.010	Why?
Retrospective Studies	4	2006	81657	0.010	Why?
Continuity of Patient Care	1	2009	1077	0.010	Why?
Gestational Age	1	2010	3617	0.010	Why?
Cardiac Pacing, Artificial	1	2006	881	0.010	Why?
Anti-Arrhythmia Agents	1	2006	772	0.010	Why?
Disability Evaluation	1	2009	1828	0.010	Why?
Natural Childbirth	1	2000	15	0.010	Why?
Sex Distribution	1	2006	2274	0.010	Why?
Cefazolin	1	2001	94	0.010	Why?
Infant, Premature	1	2010	2120	0.010	Why?
Vancomycin Resistance	1	2001	125	0.010	Why?
Methicillin Resistance	1	2001	198	0.010	Why?
Multicenter Studies as Topic	1	2006	1733	0.010	Why?
Uterine Cervical Diseases	1	2000	75	0.010	Why?
Stress, Psychological	1	2016	4526	0.010	Why?
Immunocompromised Host	1	2006	865	0.010	Why?
Cephalosporins	1	2001	200	0.010	Why?
Analysis of Variance	1	2009	6214	0.010	Why?
Florida	1	2001	417	0.010	Why?
Patient Simulation	1	2002	300	0.010	Why?
Sexual Partners	1	2005	804	0.010	Why?
Seasons	1	2006	1519	0.010	Why?
Drug Resistance	1	2006	1592	0.010	Why?
Early Diagnosis	1	2005	1186	0.010	Why?
Genetic Predisposition to Disease	1	2001	18076	0.010	Why?
Exercise	1	2016	5945	0.010	Why?
Blood Transfusion	1	2006	1308	0.010	Why?
New York	1	2001	879	0.010	Why?
Organizational Innovation	1	2002	540	0.010	Why?
Pneumonia, Viral	1	1997	3232	0.010	Why?
Organizational Policy	1	2001	434	0.010	Why?
Biopsy, Needle	1	2004	1615	0.010	Why?
Eligibility Determination	1	2002	421	0.010	Why?
Premature Birth	1	2010	1830	0.010	Why?
State Government	1	2001	388	0.010	Why?
Bacterial Infections	1	2006	1390	0.010	Why?
Diet	1	2016	8088	0.010	Why?
Length of Stay	2	2005	6491	0.010	Why?
Efficiency, Organizational	1	2002	695	0.010	Why?
Self Efficacy	1	2002	643	0.010	Why?
Saskatchewan	1	1976	8	0.010	Why?
Malaria	1	2006	1246	0.010	Why?
Guidelines as Topic	1	2002	1394	0.010	Why?
Connecticut	1	1996	365	0.010	Why?
Immunization	1	2000	1218	0.010	Why?
Statistics, Nonparametric	1	2001	2846	0.010	Why?
Enterococcus	1	1996	158	0.010	Why?
Treatment Failure	1	2001	2659	0.010	Why?
Physician's Role	1	2001	925	0.010	Why?
Bronchoalveolar Lavage Fluid	1	1997	757	0.010	Why?
Gram-Negative Bacterial Infections	1	1996	239	0.010	Why?
Interviews as Topic	1	2002	2741	0.010	Why?
Heart Rate	1	2006	4207	0.010	Why?
Gram-Positive Bacterial Infections	1	1996	340	0.010	Why?
Quality of Health Care	1	2009	4306	0.010	Why?
Craniocerebral Trauma	1	1998	493	0.010	Why?
Combined Modality Therapy	1	2006	8540	0.010	Why?
Peripheral Vascular Diseases	1	1996	488	0.010	Why?
Staphylococcus aureus	1	2001	1429	0.010	Why?
Tuberculosis	1	2006	2011	0.010	Why?
Serum Albumin	1	1996	676	0.010	Why?
Community Mental Health Services	1	1976	386	0.010	Why?
Bronchi	1	1997	847	0.010	Why?
Cross-Sectional Studies	2	2005	26309	0.010	Why?
Europe	1	1999	3430	0.010	Why?
Neoplasm Recurrence, Local	1	2010	9407	0.010	Why?
Pilot Projects	1	2005	8728	0.010	Why?
Chronic Disease	1	2006	9358	0.010	Why?
Socioeconomic Factors	1	2005	7841	0.010	Why?
Liver Transplantation	1	2003	2416	0.010	Why?
Insurance Coverage	1	2002	1945	0.010	Why?
Equipment Design	1	1998	3488	0.010	Why?
Research Design	1	2006	6206	0.010	Why?
Patient Admission	1	1996	1364	0.000	Why?
Gastrointestinal Diseases	1	1996	1203	0.000	Why?
Proportional Hazards Models	1	2002	12536	0.000	Why?
Comorbidity	1	1996	10580	0.000	Why?
Prospective Studies	1	2006	54872	0.000	Why?
Alzheimer Disease	1	2000	8715	0.000	Why?
Diabetes Mellitus	1	1996	5888	0.000	Why?

Goldie's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (532)

Explore

Co-Authors (43)

Explore

Similar People (60)

Explore

Same Department

Explore

Physical Neighbors